EKDHF Projected Dividend Yield

EKF Diagnostics Holdings PLC ( OTCBB : EKDHF )

EKF Diagnostics Holdings is a medical diagnostics business with point-of-care testing and manufacturing reagents for use in central laboratories. Co. develops, manufactures and supplies products and services into the in-vitro diagnostic market place. Co.'s product portfolios are Hemo Control™, DiaSpect™, DiaSpect Hemoglobin T Lo, UltraCrit™, HemataStat II™, Biosen™, Quo-Lab® A1c, Quo-Test® A1c, ß-Hydroxybutyrate LiquiColor & STAT-Site WB, Creamatocrit Plus™, Pregnancy Testing kits, Lactate Scout 4, Altair™ 240, Beta-Hydroxybutyrate, Procalcitonin and Lucica Glycated Albumin-L.

22 YEAR PERFORMANCE RESULTS

EKDHF Dividend History Detail
EKDHF Dividend News
EKDHF Competitors News

# of Shares: 0

Closing Price: 0.35

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
2026	0.00	0%	0	$ 0.00	0.00%
2027	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000